IGF binding protein alterations on periplaque oligodendrocytes in multiple sclerosis: Implications for remyelination

Neurochemistry International

Volumn 52, Issue 8, 2008, Pages 1431-1435

  Wilczak, Nadine ^a   Chesik, Daniel ^a   Hoekstra, Dick ^a   De Keyser, Jacques ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

IGF I; IGFBP 6; IGFBPs; Multiple sclerosis; Remyelination

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ARTICLE; CELL LINEAGE; CEREBELLUM; CONTROLLED STUDY; DEMYELINATION; FEMALE; GRAY MATTER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE SCLEROSIS; NERVE FIBER; NEUROLOGIC DISEASE; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REMYELINIZATION; WHITE MATTER;

AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE FIBERS, MYELINATED; NERVE REGENERATION; OLIGODENDROGLIA; RECEPTOR, IGF TYPE 1; SOMATOMEDINS; UP-REGULATION;

EID: 44749089363     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2008.03.004     Document Type: Article

References (38)

1. Bach L.A. IGFBP-6 five years on; not so 'forgotten'?. Growth Horm. IGF Res. 15 (2005) 185-192
2. Back S.A., Tuohy T.M., Chen H., Wallingford N., Craig A., Struve J., Luo N.L., Banine F., Liu Y., Chang A., Trapp B.D., Bebo Jr. B.F., Rao M.S., and Sherman L.S. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat. Med. 11 (2005) 966-972
3. Barres B.A., Hart I.K., Coles H.S., Burne J.F., Voyvodic J.T., Richardson W.D., and Raff M.C. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70 (1992) 31-46
4. Baxter R.C. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am. J. Physiol. Endocrinol. Metab. 278 (2000) E967-E976
5. Beck K.D., Powell-Braxton L., Widmer H.R., Valverde J., and Hefti F. Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 14 (1995) 717-730
6. Carson M.J., Behringer R.R., Brinster R.L., and McMorris F.A. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 10 (1993) 729-740
7. Chang A., Nishiyama A., Peterson J., Prineas J., and Trapp B.D. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J. Neurosci. 20 (2000) 6404-6412
8. Chang A., Tourtellotte W.W., Rudick R., and Trapp B.D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 346 (2002) 165-173
9. Charles P., Reynolds R., Seilhean D., Rougon G., Aigrot M.S., Niezgoda A., Zalc B., and Lubetzki C. Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?. Brain 125 (2002) 1972-1979
10. Chesik D., De Keyser J., Glazenburg L., and Wilczak N. Insulin-like growth factor binding proteins: regulation in chronic active plaques in multiple sclerosis and functional analysis of glial cells. Eur. J. Neurosci. 24 (2006) 1645-1652
11. Chesik D., De Keyser J., and Wilczak N. Involvement of insulin-like growth factor binding protein-2 in activated microglia as assessed in post mortem human brain. Neurosci. Lett. 362 (2004) 14-16
12. Clemmons D.R. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev. 8 (1997) 45-62
13. Davies S., Richardson M.C., Anthony F.W., Mukhtar D., and Cameron I.T. Progesterone inhibits insulin-like growth factor binding protein-1 (IGFBP-1) production by explants of the Fallopian tube. Mol. Hum. Reprod. 10 (2004) 935-939
14. De Keyser J., Wilczak N., and Goossens A. Insulin-like growth factor-I receptor densities in human frontal cortex and white matter during aging, in Alzheimer's disease, and in Huntington's disease. Neurosci. Lett. 172 (1994) 93-96
15. Gveric D., Cuzner M.L., and Newcombe J. Insulin-like growth factors and binding proteins in multiple sclerosis plaques. Neuropathol. Appl. Neurobiol. 25 (1999) 215-225
16. Ibanez C., Shields S.A., El-Etr M., Baulieu E.E., Schumacher M., and Franklin R.J. Systemic progesterone administration results in a partial reversal of the age-associated decline in CNS remyelination following toxin-induced demyelination in male rats. Neuropathol. Appl. Neurobiol. 30 (2004) 80-89
17. John G.R., Shankar S.L., Shafit-Zagardo B., Massimi A., Lee S.C., Raine C.S., and Brosnan C.F. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat. Med. 8 (2002) 1115-1121
18. Kuhl N.M., De Keyser J., De Vries H., and Hoekstra D. Insulin-like growth factor binding proteins-1 and -2 differentially inhibit rat oligodendrocyte precursor cell survival and differentiation in vitro. J. Neurosci. Res. 69 (2002) 207-216
19. Kuhl N.M., Hoekstra D., De Vries H., and De Keyser J. Insulin-like growth factor-binding protein 6 inhibits survival and differentiation of rat oligodendrocyte precursor cells. Glia 44 (2003) 91-101
20. Levine J.M., Reynolds R., and Fawcett J.W. The oligodendrocyte precursor cell in health and disease. Trends Neurosci. 24 (2001) 39-47
21. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., and Lassmann H. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 122 Part 12 (1999) 2279-2295
22. Mason J.L., Ye P., Suzuki K., D'Ercole A.J., and Matsushima G.K. Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J. Neurosci. 20 (2000) 5703-5708
23. McMorris F.A., Smith T.M., DeSalvo S., and Furlanetto R.W. Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 822-826
24. Ozawa K., Suchanek G., Breitschopf H., Bruck W., Budka H., Jellinger K., and Lassmann H. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117 (1994) 1311-1322
25. Prineas J.W., Barnard R.O., Kwon E.E., Sharer L.R., and Cho E.S. Multiple sclerosis: remyelination of nascent lesions. Ann. Neurol. 33 (1993) 137-151
26. Raine C.S., and Wu E. Multiple sclerosis: remyelination in acute lesions. J. Neuropathol. Exp. Neurol. 52 (1993) 199-204
27. Roth G.A., Spada V., Hamill K., and Bornstein M.B. Insulin-like growth factor I increases myelination and inhibits demyelination in cultured organotypic nerve tissue. Brain Res. Dev. Brain Res. 88 (1995) 102-108
28. Scolding N., Franklin R., Stevens S., Heldin C.H., Compston A., and Newcombe J. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 121 (1998) 2221-2228
29. Seifert T., Bauer J., Weissert R., Fazekas F., and Storch M.K. Notch1 and its ligand Jagged1 are present in remyelination in a T-cell- and antibody-mediated model of inflammatory demyelination. Acta Neuropathol. 113 (2007) 195-203
30. Stidworthy M.F., Genoud S., Li W.W., Leone D.P., Mantei N., Suter U., and Franklin R.J. Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. Brain 127 (2004) 1928-1941
31. Torres-Aleman I., Barrios V., and Berciano J. The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis. Neurology 50 (1998) 772-776
32. Viehover A., Miller R.H., Park S.K., Fischbach G., and Vartanian T. Neuregulin: an oligodendrocyte growth factor absent in active multiple sclerosis lesions. Dev. Neurosci. 23 (2001) 377-386
33. Wilczak N., Schaaf M., Bredewold R., Streefland C., Teelken A., and De Keyser J. Insulin-like growth factor system in serum and cerebrospinal fluid in patients with multiple sclerosis. Neurosci. Lett. 257 (1998) 168-170
34. Wolswijk G. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain 123 (2000) 105-115
35. Wolswijk G. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 125 (2002) 338-349
36. Ye P., Carson J., and D'Ercole A.J. In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J. Neurosci. 15 (1995) 7344-7356
37. Ye P., Carson J., and D'Ercole A.J. Insulin-like growth factor-I influences the initiation of myelination: studies of the anterior commissure of transgenic mice. Neurosci. Lett. 201 (1995) 235-238
38. Ye P., and D'Ercole A.J. Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-alpha-induced injury. Endocrinology 140 (1999) 3063-3072